China SXT Pharmaceuticals, Inc.
SXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723980
No open-market purchases or sales by China SXT Pharmaceuticals, Inc. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $6 in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding China SXT Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 4 | 8 | +4 |
| Shares | 146.6K | 480.5K | +333.9K (+227.8%) |
| Value | $32.3K | $57.0K | +$24.8K (+76.7%) |
New holders (6)
Institutions that held China SXT Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 191,339 | $23.5K | 0.00% |
| Level Four Advisory Services, LLC | 42,771 | $5.26K | 0.00% |
| HRT Financial LP | 48,507 | $5.00K | 0.00% |
| UBS Group AG | 29,870 | $3.67K | 0.00% |
| Baader Bank INC | 12,916 | $1.42K | 0.00% |
| Qube Research & Technologies Ltd | 50 | $6 | 0.00% |
Sold out (2)
Institutions that held China SXT Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Cetera Advisor Networks LLC | 10,415 | $2.45K |
| Renaissance Technologies LLC | 10,540 | $2.00K |